Last updated: September 28, 2023
Sponsor: Ankara City Hospital Bilkent
Overall Status: Active - Recruiting
Phase
4
Condition
Pain
Treatment
Dexketoprofen
Ibuprofen 800 mg
Clinical Study ID
NCT06060236
E2-23-4743
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- over 18 years
- Patients under 80 years of age
- Patients who agreed to participate in the study
- One of the tibia, femur and humerus bones is broken
- Patients with a VAS score of 50 and above
- Patients with no other injuries requiring emergency surgery
- Previously known adverse reactions to the active ingredient of the drugs to be usedpatients with no history
- Conscious patients
- Oriented cooperative patients
Exclusion
Exclusion Criteria:
- Patients under the age of 18 and over the age of 80
- Patients who did not agree to participate in the study
- Patients with vital signs outside the normal limits
- Patients with a history of adverse reactions to known NSAIDs
- Those who cannot determine the severity of pain on the VAS
- Patients with a VAS Score of 50 mm or less
- Those with other orthopedic injuries pregnant women
- Those with advanced systemic disease
- Those with malignancy
- Those with chronic liver and kidney disease
- Those who use neuro-psychiatric drugs with sedative and analgesic effects
- Those with a history of psychological and neurological diseases
- Patients using analgesics 8 hours before the examination
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Dexketoprofen
Phase: 4
Study Start date:
September 01, 2023
Estimated Completion Date:
September 01, 2024
Study Description
Connect with a study center
Ankara Bilkent Şehir Hastanesi
Ankara, 06170
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.